The Spanish National Registry for Myotonic Dystrophy Type 1
Creación de un Nodo Integral Para la Distrofia Miotónica Tipo 1 en España: Registro clínico, Mapas genómicos, epigenómicos y proteómicos (DM1-Hub)
Fundació Institut Germans Trias i Pujol
3,000 participants
Jun 2, 2025
OBSERVATIONAL
Conditions
Summary
Myotonic Dystrophy Type 1 (DM1) is a rare genetic neuromuscular condition that can affect multiple organs and varies widely in how it presents. DM1 is the most common form of adult-onset muscular dystrophy, with an estimated prevalence of approximately 1-5 per 10,000 people. In Spain, the condition shows notable regional differences, making it especially important to understand its characteristics within the population. The aim of this study is to support a research initiative designed to better characterise DM1. We are developing a comprehensive national registry, collecting patient-reported information, clinical data and omics data that will improve our understanding of the disease and help identify individuals who may be eligible for clinical trials.
Eligibility
Inclusion Criteria1
- Confirmed diagnosis of Myotonic Dystrophy Type 1 (DM1) through genetic testing.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patient Registry
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07385443